Lupin secures S&P Global ESG Score of 91 for 2025 Ruchika Sharma17 Nov 2025 12:34 PM ISTMumbai: Global pharma firm Lupin Limited has announced that it has achieved an S&P Global ESG Score of 91 for 2025, well above the...
Lupin Nagpur facility completes USFDA inspection Ruchika Sharma15 Nov 2025 5:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a product...
Lupin unveils Risperidone Long Acting Injectable in US Ruchika Sharma14 Nov 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial,...
Lupin gets EIR from USFDA for Aurangabad Facility Ruchika Sharma13 Nov 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
Lupin Bioresearch Center gets zero USFDA observation after successful inspection, assessment Ruchika Sharma8 Nov 2025 3:08 PM ISTMumbai: Lupin Limited, a Global pharma major, has announced that the United States Food and Drug Administration (U.S. FDA) has...
Lupin gets USFDA EIR for Pithampur Unit 3 facility Ruchika Sharma6 Nov 2025 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
Lupin inaugrates new corporate offices in New Jersey Ruchika Sharma29 Oct 2025 11:30 AM ISTBridgewater: Global pharmaceutical leader, Lupin Limited, has announced the inauguration of its new corporate offices at 100 Somerset...
Lupin unveils authorized generic version of Ravicti in US Ruchika Sharma24 Oct 2025 2:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of an authorized generic version of Ravicti (Glycerol Phenylbutyrate) Oral Liquid,...
Lupin gets 1 USFDA observation for Somerset facility Ruchika Sharma12 Oct 2025 2:45 PM ISTMumbai: Lupin has announced that the company has received one observation from the U.S. Food and Drug Administration (USFDA) after a Pre-Approval...
Lupin plans to build new pharma manufacturing plant in Coral Springs Ruchika Sharma9 Oct 2025 12:00 PM ISTCoral Springs: Global pharmaceutical company, Lupin, has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in...
Lupin gets USFDA OAI status for Pithampur Unit 2 facility Ruchika Sharma5 Oct 2025 11:00 AM ISTMumbai: Lupin has announced that the U.S. Food and Drug Administration (USFDA) has issued Official Action Indicated (OAI) status for the...
Lupin unveils Liraglutide Injection in US for diabetes Ruchika Sharma4 Oct 2025 10:32 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen,...
